Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.125 USD | -5.38% | -10.38% | -30.89% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 181
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Device
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rebecca Kuhn
FOU | Founder | 64 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Cairn Seale
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-12-31 |
Martha Morrell
CTO | Chief Tech/Sci/R&D Officer | 66 | 97-11-18 |
Philip Taylor
IRC | Investor Relations Contact | - | - |
Stacey Ellul
LAW | General Counsel | - | 22-11-30 |
Irene Thomas
HRO | Human Resources Officer | 55 | 99-12-31 |
Dylan St. John
PRN | Corporate Officer/Principal | 46 | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Andrade
BRD | Director/Board Member | 52 | 21-10-31 |
Joseph Lacob
BRD | Director/Board Member | 68 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Uri Geiger
BRD | Director/Board Member | 56 | 23-01-04 |
Renee Ryan
BRD | Director/Board Member | 55 | 20-07-31 |
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rakhi Kumar
BRD | Director/Board Member | 44 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,768,128 | 23,068,317 ( 80.19 %) | 0 | 80.19 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.96% | 217M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+3.08% | 65.19B | |
+15.38% | 53.02B | |
+3.64% | 50.28B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- NPCE Stock
- Company NeuroPace, Inc.